journal cover

Activity of novel antifungal compound APX001A against a large collection of Candida auris

The Journal of Antimicrobial Chemotherapy

Aug 8, 2018

Elizabeth L Berkow, Shawn R Lockhart

Download from

Publisher
PubMed

Abstract

APX001A is an antifungal agent that targets a novel pathway-glycosylphosphatidylinositol glycolipid biosynthesis. It has been shown to be effective against a variety of fungal species, including Candida spp., Aspergillus spp. and other filamentous fungi. To determine the activity of APX...read more

Mentioned in this Paper

Biochemical Pathway
Corynebacterium auris
Pathogenic Organism
Antibiotics, Antifungal
Filamentous fungus
Candida (fungus)
Isolate - Microorganism
Fungi
Species
Aspergillus
5
22
Paper Details
References
  • References
  • Citations4
  • finger pointing at paper

    References currently unavailable

    We're still populating references for this paper, please check back later.
  • References
  • Citations4
1

Feeds With Similar Papers

Multi-drug Resistance

Multi-drug resistance or multiresistance is antimicrobial resistance shown by a species of microorganism to multiple antimicrobial drugs. Discover the latest research on multi-drug resistance here.

GPI Anchoring

Glycosylphosphatidylinositol (GPI) is a glycolipid anchor for several cell-surface proteins that play a role in various biological processes, including signal transduction, prion disease pathogenesis, and immune response. Here is the latest research.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Multi-drug Resistance (ASM)

Multi-drug resistance or multiresistance is antimicrobial resistance shown by a species of microorganism to multiple antimicrobial drugs. Discover the latest research on multi-drug resistance here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Related Papers

Diagnostic Microbiology and Infectious Disease

Activity of CD101, a long-acting echinocandin, against clinical isolates of Candida auris

Diagnostic Microbiology and Infectious DiseaseJanuary 9, 2018
Elizabeth L Berkow, Shawn R Lockhart
© 2020 Meta ULC. All rights reserved

Activity of novel antifungal compound APX001A against a large collection of Candida auris

The Journal of Antimicrobial Chemotherapy

Aug 8, 2018

Elizabeth L Berkow, Shawn R Lockhart

PMID: 30085167

DOI: 10.1093/jac/dky302

Abstract

APX001A is an antifungal agent that targets a novel pathway-glycosylphosphatidylinositol glycolipid biosynthesis. It has been shown to be effective against a variety of fungal species, including Candida spp., Aspergillus spp. and other filamentous fungi. To determine the activity of APX...read more

Mentioned in this Paper

Biochemical Pathway
Corynebacterium auris
Pathogenic Organism
Antibiotics, Antifungal
Filamentous fungus
Candida (fungus)
Isolate - Microorganism
Fungi
Species
Aspergillus
5
22

Feeds With Similar Papers

Multi-drug Resistance

Multi-drug resistance or multiresistance is antimicrobial resistance shown by a species of microorganism to multiple antimicrobial drugs. Discover the latest research on multi-drug resistance here.

GPI Anchoring

Glycosylphosphatidylinositol (GPI) is a glycolipid anchor for several cell-surface proteins that play a role in various biological processes, including signal transduction, prion disease pathogenesis, and immune response. Here is the latest research.

Related Papers

Diagnostic Microbiology and Infectious Disease

Activity of CD101, a long-acting echinocandin, against clinical isolates of Candida auris

Diagnostic Microbiology and Infectious DiseaseJanuary 9, 2018
Elizabeth L Berkow, Shawn R Lockhart
Paper Details
References
  • References
  • Citations4
  • finger pointing at paper

    References currently unavailable

    We're still populating references for this paper, please check back later.
  • References
  • Citations4
1

Download from

Publisher
PubMed
/papers/activity-of-novel-antifungal-compound-apx001a/30085167